# FDA Inspection 1182340 - Taejoon Pharmaceutical Co., Ltd. - October 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/taejoon-pharmaceutical-co-ltd/0a99edfc-34a3-45ad-affd-9bd3e671a129
Source feed: FDA_Inspections

> FDA Inspection 1182340 for Taejoon Pharmaceutical Co., Ltd. on October 18, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182340
- Company Name: Taejoon Pharmaceutical Co., Ltd.
- Inspection Date: 2022-10-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1106379 - 2019-10-15](https://www.keypedia.com/records/fda_inspections/taejoon-pharmaceutical-co-ltd/125fb7e3-c092-4586-abaa-5795bc47b8de)
- [FDA Inspection 994512 - 2016-11-15](https://www.keypedia.com/records/fda_inspections/taejoon-pharmaceutical-co-ltd/46ed1b67-b0d8-400c-be70-4f414f51eb95)

Company: https://www.keypedia.com/companies/taejoon-pharmaceutical-co-ltd/ad1de54a-aca7-4940-97f8-555c2a55f2b1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c